← FDA Drug Approvals (Drugs@FDA)

NOREPINEPHRINE BITARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2022-07-19

Drug application

FDA Application #

ANDA216341

Application type

Abbreviated New Drug Application (Generic)

Brand name

NOREPINEPHRINE BITARTRATE

Generic name

Norepinephrine Bitartrate

Active ingredients

NOREPINEPHRINE BITARTRATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

ZYDUS PHARMS

First approval

2022-07-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown